Levetiracetam
NDC 50405-302, Levetiracetam, tablet, from SOHM, Inc..
- Product NDC
- 50405-302
- Status
- Listed
- Labeler
- SOHM, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA079042
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50405-302 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM750 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50405-302-01 | 50405030201 | 30 TABLET in 1 BOTTLE (50405-302-01) |
| 50405-302-02 | 50405030202 | 120 TABLET in 1 BOTTLE (50405-302-02) |
| 50405-302-03 | 50405030203 | 500 TABLET in 1 BOTTLE (50405-302-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0a688786-879b-4e27-a46a-5c86bbfa1292
Use it
Look up 50405-302 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50405-302 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50405-302. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.